Relationship between comorbidity and health outcomes in patients with heart failure: a systematic review and meta-analysis
Open Access
- 10 October 2023
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 23 (1) , 1-16
Abstract
Background: The prevalence of heart failure (HF) is expected to rise due to increased survivorship and life expectancy of patients with acute heart conditions. Patients with HF and other multiple comorbid conditions are likely to have poor health outcomes. This study aimed to assimilate the current body of knowledge and to provide the pooled effect of HF patients’ comorbid conditions on health outcomes. Methods: A systematic search was performed using MEDLINE, EMBASE and CINAHL databases. Observational studies evaluating the relationship between comorbid conditions and the health outcomes of HF were included. The pooled effect sizes of comorbidity on the identified health outcomes were calculated using a random effects model, and the heterogeneity was evaluated using I2 statistics. Results: A total of 42 studies were included in this review, and a meta-analysis was performed using the results of 39 studies. In the pooled analysis, the presence of a comorbid condition showed a significant pooled effect size in relation to the prognostic health outcomes: all-cause mortality (HR 1.31; 95% CI 1.18, 1.45), all-cause readmission (HR 1.16; 95% CI 1.09, 1.23), HF-related readmission (HR 1.13; 95% CI 1.05, 1.23), and non-HF-related readmission (HR 1.17; 95% CI 1.07, 1.27). Also, comorbidity was significantly associated with health-related quality of life and self-care confidence. Furthermore, we identified a total of 32 comorbid conditions from included studies. From these, 16 individual conditions were included in the meta-analyses, and we identified 10 comorbid conditions to have negative effects on overall prognostic outcomes: DM (HR 1.16, 95% CI 1.11, 1.22), COPD (HR 1.31, 95% CI 1.23, 1.39), CKD (HR 1.18, 95% CI 1.14, 1.23, stroke (HR 1.25, 95% CI 1.17, 1.31), IHD (HR 1.17, 95% CI 1.11, 1.23), anemia (HR 1.42, 95% CI 1.14, 1.78), cancer (HR 1.17, 95% CI 1.04, 1.32), atrial fibrillation (HR 1.25, 95% CI 1.01, 1.54), dementia (HR 1.19, 95% CI 1.03, 1.36) and depression (HR 1.17, 95% CI 1.04, 1.31). Conclusions: Comorbid conditions have significantly negative pooled effects on HF patient health outcomes, especially in regard to the prognostic health outcomes. Clinicians should carefully identify and manage these conditions when implementing HF interventions to improve prognostic outcomes.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (2021R1C1C100849812)
- Ministry of Education (MOE, Korea) and National Research Foundation of Korea (BK21 FOUR project (Center for Human-Caring Nurse Leaders for the Future))
- 2022 Hannam University Research Fund
This publication has 69 references indexed in Scilit:
- Predictors of Rehospitalization in Patients Admitted With Heart Failure in Abeokuta, Nigeria: Data From the Abeokuta Heart Failure RegistryJournal of Cardiac Failure, 2014
- Effect of the Readmission Primary Diagnosis and Time Interval in Heart Failure Patients: Analysis of English Administrative DataEuropean Journal of Heart Failure, 2014
- Co-Morbidities in Patients with Heart Failure: An Analysis of the European Heart Failure Pilot SurveyEuropean Journal of Heart Failure, 2013
- Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validityJournal of Clinical Epidemiology, 2013
- Risk Factors for Hospital Admission Among Older Persons With Newly Diagnosed Heart FailureJACC, 2013
- Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studiesEuropean Heart Journal, 2012
- Association of Depression and Survival in Patients with Chronic Heart Failure over 12 YearsPsychosomatics, 2012
- The Effect of Guided Care Teams on the Use of Health ServicesArchives of internal medicine (1960), 2011
- A basic introduction to fixed-effect and random-effects models for meta-analysisResearch Synthesis Methods, 2010
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002